Impact of prophylactic HPV vaccines on dermatology and venereology;Bedeutung der prophylaktischen HPV-vakzine für die dermatologie und venerologie

Hautarzt

Volumn 58, Issue 6, 2007, Pages 507-514

  Gross, G ^a,b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Anogenital carcinomas; Anogenital warts; Bivalent L1 VLP HPV16, 18 vaccine; HPV vaccines; Quadrivalent L1 VLP HPV6, 11, 16, 18 vaccine

Indexed keywords

WART VIRUS VACCINE;

ANUS CARCINOMA; ARTICLE; CANCER IMMUNIZATION; CONDYLOMA ACUMINATUM; DRUG APPROVAL; GENITAL TRACT CANCER; GERMANY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION PREVENTION; MOUTH CANCER; PENIS CARCINOMA; SKIN CANCER; VIRUS LIKE AGENT;

DERMATOLOGY; GERMANY; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SEXUALLY TRANSMITTED DISEASES, VIRAL; SKIN DISEASES, VIRAL; VENEREOLOGY;

EID: 34250315802     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-007-1349-2     Document Type: Article

References (67)

1. Adach A, Fleming I, Burk RD et al. (1993) Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome. Obstet Gynecol 81: 372-377
2. Block SL, Nolan T, Sattler C et al. (2006) Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 118: 2135-2145
3. Bosch FX, Maros MM, Munoz N et al. (1995) Prevalence of human Papillomavirus in cervical cancer: a world-wide perspective. International biological study on cervical cancer (IBSCC) Study group: J Natl Cancer Inst 87: 796-802
4. Breese PL, Judson FN, Penley KA, Douglas JM Jr (1995) Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus. Sex Transm Dis 22: 7-14
5. Byrne MA, Taylor-Robinson D, Munday PE, Harris JR (1989) The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV. AIDS 3: 379-382
6. Center for Disease Control and Prevention (2002) Age-adjusted cancer strategies
7. Chang MH, Chen TH, Hsu HM et al. (2005) Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 11: 7953-7957
8. Chuang TY, Perry HO, Kurland LT, Ilstrup DM (1984) Condyloma acuminatum in Rochester, Minn., 1950-1978. I. Epidemiology and clinical features. Arch Dermatol 120: 469-475
9. Clifford GM, Gallus S, Herrero R et al. (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366: 991-998
10. Colgrave J (2006) The ethics and politics of compulsory HPV vaccination. N Engl J Med 355: 2389-2391
11. Critchlow CW, Hawes SE, Kuypers JM et al. (1998) Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS 12: 1177-1184
12. Cupp MR, Malek RS, Goellner JR et al. (1995) The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 154: 1024-1029
13. Daling JR, Madeleine MM, Johnson LG et al. (2005) Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 116: 606-616
14. De Villiers EM (1989) Prevalence of HPV 7 papillomas in the oral mucosa and facial skin of patients with human immunodeficiency virus. Arch Dermatol 125: 1590
15. De Villiers EM, Sandstrom RE, Hausen H zur, Buck CE (2005) Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 7: R1-R11
16. Dillner J, Krogh G von, Horenblas S, Meijer CJ (2000) Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl 205: 189-193
17. Frazer IH, Medley G, Crapper RM et al. (1986) Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet 2: 657-660
18. French MA, Lenzo N, John M et al. (2000) Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 1: 107-115
19. Frisch M, Glimelius B, Brule AJ van den et al. (1997) Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337: 1350-1358
20. Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92: 1500-1510
21. Garnett GP (2005) Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis (Suppl 1) 191: S97-S106
22. Gerber GS (1994) Carcinoma in situ of the penis. J Urol 151: 829-833
23. Gillison ML, Koch WM, Capone RB et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720
24. Greenspan D, Villiers EM de, Greenspan JS et al. (1988) Unusual HPV types in oral warts in association with HIV infection. J Oral Pathol 17: 482-488
25. Gross G, Hagedorn M, Ikenberg H et al. (1985) Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol 121: 858-863
26. Gross G (2001) Klinik und Therapie anogenitaler Warzen und HPV-assoziierter Krankheitsbilder. Hautarzt 52: 6-17
27. Gross G, Pfister H (2004) Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol 193: 35-44
28. Gross G, für das Deutsche HPV-Management-Forum (2006) Wer soll wann, wo und wie geimpft werden. Antworten des HPV.Management-Forums auf viel diskutierte Fragen, die mit Einführung von zwei unterschiedlichen HPV-Impfstoffen zur Prävention des Zervixkarzinoms und der Condylomata acuminata in Zusammenhang stehen. Dtsch Arztebl 103: 3384-3388
29. Gross G (2007a) Condylomata acuminata und andere HPV-assoziierte Krankheitsbilder von Genitale, Anus und Harnröhre. Leitlinie der Deutschen STD-Gesellschaft in Zusammenarbeit mit der Deutschen Dermatologischen Gesellschaft und der Paul-Ehrlich-Gesellschaft. Hautarzt 58: 179-186
30. Gross G (2007b) HPV-vaccination against cervical carcinoma: will it really work? Med Microbiol Immunol: DOI: 10.1007/s00430-007-0039-0 (Springer Verlag; online first)
31. Holly EA, Ralston ML, Darragh TM et al. (2001) Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 93: 843-849
32. Hughes JP, Garnett GP, Koutsky L (2002) The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology 13: 631-639
33. Ikenberg H, Gissmann L, Gross G et al. (1983) Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer 32: 563-565
34. Insinga RP, Dasbach EJ, Myers ER et al. (2003) The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 36: 1397-1403
35. Iversen T, Tretli S (1998) Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway. Obstet Gynecol 91: 969-972
36. Klussmann JP, Dinh S, Guntinas-Lichius O et al. (2004) HPV-associated tonsillar cancer. An update. HNO 52: 208-218
37. Koshiol JE, Laurent SA, Pimenta JM (2004) Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis 31: 748-752
38. Koutsky LA, Galloway DA, Holmes KK (1988) Epidemiology of genital human papillomavirus infection. Epidemiol Rev 10: 122-163
39. Lacey CJ, Lowndes CM, Shah KV (2006) Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine (Suppl 3) 24: S35-S41
40. Lee J, Smith R (2005) Recurrent respiratory papillomatosis: pathogenesis to treatment. Current Opin Otolaryngol Head Neck Surg 13: 354-359
41. Lillo FB, Ferrari D, Veglia F et al. (2001) Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 184: 547-551
42. Louie JK, Hsu LC, Osmond DH et al. (2002) Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis 186: 1023-1027
43. Minkoff H, Ahdieh L, Massad LS et al. (2001) The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 15: 2157-2164
44. Naghasfar Z, McDonnell PJ, McDonnell JM et al. (1986) Genital tract papillomavirus type 6 in recurrent conjunctival papilloma. Arch Ophthalmol 104: 1814-1815
45. Paidas CN, Morreale RF, Holoski KM et al. (1999) Septation and differentiation of the embryonic human cloaca. J Pediatr Surg 34: 877-884
46. Palefsky JM, Holly EA, Ralston ML et al. (1997) Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin Med 73: 174-180
47. Palefsky J (1995) Human papillomavirus-associated malignancies in HIV-positive men and women. Curr Opin Oncol 7: 437-441
48. Palefsky JM (2000) Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol 27: 471-479
49. Palefsky JM, Holly EA, Efirdc JT et al. (2005) Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 19: 1407-1414
50. Pao CC, Tsai PL, Chang YL et al. (1993) Possible non-sexual transmission of genital human papillomavirus infections in young women. Eur J Clin Microbiol Infect Dis 12: 221-222
51. Piketty C, Darragh TM, Heard I et al. (2004) High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 31: 96-99
52. Rubin MA, Kleter B, Zhou M et al. (2001) Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 159: 1211-1218
53. Seck AC, Faye MA, Critchlow CW et al. (1994) Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV. Int J STD AIDS 5: 189-193
54. Simms I, Fairley CK (1997) Epidemiology of genital warts in England and Wales: 1971 to 1994. Genitourin Med 73: 365-367
55. Slater PE, Roitman M, Leventhal A, Anis E (1996) Control of rubella in Israel: progress and challenge. Public Health Rev 24: 183-192
56. Sonnex C, Strauss S, Gray JJ (1999) Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect 75: 317-319
57. Steinberg BM, DiLorenzo TP (1996) A possible role for human papillomaviruses in head and neck cancer. Cancer Metastasis Rev 15: 91-112
58. Strickler HD, Schiffman MH, Shah KV et al. (1998) A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. Eur J Cancer Prev 7: 305-313
59. Syrjänen S (2005) Human papillomavirus (HPV) in head and neck cancer. J Clin Virol (Suppl 1) 32: S59-S66
60. Tay SK, Ho TH, Lim-Tan SK (1990) Is genital human papillomavirus infection always sexually transmitted? Aust N Z J Obstet Gynaecol 30: 240-242
61. Viac J, Chardonnet Y, Euvrard S et al. (1992) Langerhans cells, inflammation markers and human papillomavirus infections in benign and malignant epithelial tumors from transplant recipients. J Dermatol 19: 67-77
62. Villa LL, Costa RL, Petta CA et al. (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6: 271-278
63. Von Krogh G, Lacey CJ, Gross G et al. (2000) European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 76: 162-168
64. Walboomers JM, Jacobs MV, Manos MM et al. (1999) Human papillomavirus necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19
65. Wiatrak BJ (2003) Overview of recurrent respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg 11: 433-441
66. Winer RL, Lee SK, Hughes JP et al. (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157: 218-226
67. www.awmf-leitlinien.de S3-Leitlinie.,Impfprävention HPV-assoziierter Neoplasien" (Fertigstellung in 12/2007) AWMF-Leitlinien-Register Nr. 082/002